Journal of Thoracic Oncology:
doi: 10.1097/01.JTO.0000445598.81357.ff
Submitted Abstracts

Drug Index

Free Access

17-DMAG – 53P

Afatinib – 103P

Bevacizumab – 68P, 101P, 106P, 119P, 125P

Bortezomib – 53P

Bosutinib – 49P, 54P

Cabazitaxel – 67O

Cabozantinib – 94O

Carboplatin – 20P, 41P, 42P, 56P, 66O, 76P, 77P, 86P, 100PD, 105P, 108P

Cetuximab – 49P, 70P, 100PD

Cisplatin – 10P, 20P, 41P, 42P, 43P, 47P, 55P, 66O, 70P, 76P, 77P, 85P, 86P, 87P, 88P, 91O, 99PD, 101P, 105P, 108P, 113P, 114P, 115P, 116P, 118P

CO-1686 – 93O

Crizotinib – 92O

Cyclophosphamide – 66O, 69P, 70P

Darbepoetin alfa – 122P, 123TiP

Dasatinib – 49P, 54P

Debio 1143 – 45P, 46P

Docetaxel – 42P, 86P, 97PD

Doxorubicin – 22P, 66O, 69P

Erlotinib – 38O, 49P, 91O, 92O, 99PD, 103P, 107P, 111P

Etoposide – 66O, 70P, 85P, 87P, 88P

Gantespib – 39PD

Gefitinib – 38O, 49P, 92O, 95PD, 103P

Gemcitabine – 42P, 55P, 86P, 91O, 99PD, 115P, 116P

IL2 – 120P

Methotrexate – 70P

Nintedanib – 97PD

Nivolumab – 96PD, 102P

Paclitaxel – 42P, 56P, 68P, 77P, 86P, 100PD

Pemetrexed – 41P, 55P, 101P, 113P, 114P

PGG beta-glucan – 100PD

Ponatinib – 94O

Saracitinib – 49P

Selumetinib – 49P

Sunitinib – 94O

Temozolomide – 117P

Topotecan – 66O, 67O, 69P

Ubenimex – 75PD

Vandetanib – 94O

Vincristine – 66O, 69P, 70P

Vinorelbine – 42P, 43P, 77P, 86P

Vintafolide – 50P, 60P

Copyright © 2014 by the European Lung Cancer Conference and the International Association for the Study of Lung Cancer.


Article Tools


Other Ways to Connect



Visit on your smartphone. Scan this code (QR reader app required) with your phone and be taken directly to the site.

 For additional oncology content, visit LWW Oncology Journals on Facebook.